(Q40480957)

20 September 2017

title

Safety and immunogenicity of the modified adult tick-borne encephalitis vaccine FSME-IMMUN: results of two large phase 3 clinical studies. (English)

1 reference

tick-borne encephalitis vaccine

20 September 2017

main subject

tick-borne encephalitis

1 reference

based on heuristic

inferred from title

1 reference

A Loew-Baselli

1

1 reference

20 September 2017

R Konior

2

1 reference

20 September 2017

B G Pavlova

3

1 reference

20 September 2017

S Fritsch

4

1 reference

20 September 2017

E Poellabauer

5

1 reference

20 September 2017

F Maritsch

6

1 reference

20 September 2017

P Harmacek

7

1 reference

20 September 2017

M Krammer

8

1 reference

20 September 2017

P N Barrett

9

1 reference

20 September 2017

H J Ehrlich

10

1 reference

20 September 2017

FSME-IMMUN study group

11

1 reference

20 September 2017

language of work or name

English

0 references

publication date

3 April 2006

1 reference

20 September 2017

1 reference

20 September 2017

volume

24

1 reference

20 September 2017

issue

24

1 reference

20 September 2017

page(s)

5256-5263

1 reference

20 September 2017

cites work

History of TBE vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.03.061

Tick-borne encephalitis--pathogenesis, clinical course and long-term follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.03.061

TBE vaccination and the Austrian experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.03.061

Randomized, phase II dose-finding studies of a modified tick-borne encephalitis vaccine: evaluation of safety and immunogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.03.061

A new vaccine against tick-borne encephalitis: initial trial in man including a dose-response study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.03.061

A randomized phase II study of a new tick-borne encephalitis vaccine using three different doses and two immunization regimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.03.061

Pharmacokinetics of human tick-borne encephalitis virus antibody levels after injection with human tick-borne encephalitis immunoglobulin, solvent/detergent treated, FSME-BULIN S/D in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.03.061

Test-based exact confidence intervals for the difference of two binomial proportions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.03.061

Clinical evaluation of a polygeline-free tick-borne encephalitis vaccine for adolescents and adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.03.061

The results of tick-bone encephalitis (TBE)-vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.03.061

10.1016/J.VACCINE.2006.03.061

7 January 2021

Identifiers

DOI

1 reference

20 September 2017

1 reference